Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma
Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma
Recruiting · NCT03364530 · Registry updated 2026-01-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma | Cholangiocarcinoma Non-resectable; Non-metastatic | Recruiting | Phase 2 | 2026-01-05 | NCT03364530 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Federation Francophone de Cancerologie Digestive | 19 |
| University Hospital, Montpellier | 211 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Amiens university hospital | Amiens | France | 5 |
| Angers University hospital | Angers | France | 14 |
| Bordeaux university hospital | Bordeaux | France | 15 |
| Centre Georges François Leclerc | Dijon | France | 35 |
| Hôpital Européen Georges Pompidou | Paris | France | 20 |
| Institut Gustave Roussy | Villejuif | France | 58 |
| Uhmontpellier | Montpellier | France | 5 |